UnitedHealth Group (UNH) Stock Price & Analysis

UNH$409.38—
Medical - Healthcare PlansMega Cap
Compare
Market cap$361.04BEnterprise value$415.94BRevenue (TTM)$449.66BMarket positionTop 5%

Score

42
Bearish
Value
58
Quality
32
Growth
35

AI Analysis

Snapshot

UnitedHealth Group doesn’t screen as a clean setup today — Stocklytics 42/100 leaves more to prove. Under the hood: P/E 23.4, plus revenue compounding ~11% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

58
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

35
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

32
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

UnitedHealth Group Incorporated (UNH) last printed $409.38. Equity value is $361.04B. Trailing earnings multiple 22.85. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$184.84B$201.16B$226.25B$242.16B$257.14B$287.6B$324.16B$371.62B$400.28B$447.57B

About

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.

UnitedHealth Group (UNH) Stock Price & Analysis

UNH price $409.38 —

Ticker
UNH
Price
$409.38
Change
—
Market cap
$361.04B
P/E
22.85
Forward P/E
17.88
Dividend yield
2.21%
Beta
0.61
Sector
Healthcare
Industry
Medical - Healthcare Plans
Stocklytics score
42
Value
58
Quality
32
Growth
35

Stocklytics score rationale: value 58, quality 32, growth 35.

AI Score 75. UnitedHealth Group has a strong market capitalization of $363 billion and a stable beta of 0.615, indicating lower volatility. However, its current ratio of 0.739 suggests potential liquidity concerns, and a price-to-earnings ratio of 23.1 indicates it may be overvalued relative to earnings growth, which is negative at -2.58%

Summary

UnitedHealth Group Incorporated operates in Healthcare, within the Medical - Healthcare Plans industry. The company pays a dividend with a yield of 2.3%.

Valuation

The shares trade at a price-to-earnings ratio of 22.9 and a price-to-book ratio of 3.5. These figures provide the available valuation context.

Quality

Net margin is 3.5%, indicating the company retains a portion of revenue after expenses. Additional balance-sheet, cash-flow, and return metrics are not provided.

Growth

No revenue, earnings, estimate, or price-trend growth data is provided. Growth cannot be assessed from the available facts.

Risks

The available data does not include debt, cash flow, earnings estimates, or price performance. The Medical - Healthcare Plans industry may also be sensitive to factors not detailed in the facts.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener